Rajasekaran et al.'s study showed that SMC2 was significantly more pronounced in retinoblastoma patients than in healthy individuals, but the exact mode of action of this protein in retinoblastoma is still unknown [50]. This evidence concerns the gene SMC2 and retinoblastoma.